Fig. 5 | Scientific Reports

Fig. 5

From: Development of a prognostic multiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first line immunotherapy

Fig. 5

Progression-free survival analysis for 210 patients with non-squamous carcinoma built using (a) clinical model (BMI, smoking status) (b) combination model (radiomic phenotypes, radiological variables (SUVmax, longest tumor diameter at baseline), pathological variable (PD-L1 expression) (c) combination clinical model (d) multiomic graph phenotypes and (e) multiomic graph clinical model.

Back to article page